A recent large study conducted in Sweden has found that long-term exposure to elevated levels of air pollution may increase ...

Half of the planned 200 ALS patients have joined Medicinova’s expanded access program evaluating the experimental drug MN-166.

A new survey suggests many people with ALS would value even modest slowing of ALS progression as a treatment goal.

A new drug may slow progression of — and even reverse — symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...

Please provide your email address to receive an email when new articles are posted on . The treatment group logged longer times to four disease-progression milestones compared with controls. At 2 ...

Long-term exposure to common air pollutants is associated with a higher risk of developing motor neuron disease (MND), as well as faster functional decline and poorer survival after diagnosis — even ...

ALS is a progressive disease, meaning it worsens over time. Although there is no cure for ALS, medications and therapies are available to help manage the symptoms, slow the disease course, and prolong ...

The TikTok star, 37, was officially diagnosed with the terminal neurodegenerative disease in 2022 ...

Scientists at Northwestern University have developed a new approach that directly combats the progression of neurodegenerative diseases like Alzheimer's disease and amyotrophic lateral sclerosis (ALS) ...

ARLINGTON, Va., Feb. 3, 2026 /PRNewswire/ -- The ALS Association today applauded the reintroduction of the ALS Better Care Act bipartisan legislation to expand access to high-quality multidisciplinary ...

Rickey Malloy (left), who receives tofersen treatment for SOD1-ALS at WashU Medicine, plays a round of golf with his wife, Jenny, and their son, Kash. Long-term use of tofersen, a new drug approved by ...